(Q83586721)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396197%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Clinical trials of HDL cholesterol-raising therapy: what have we learned about the HDL hypothesis from AIM-HIGH? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396197%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Robert S Rosenson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396197%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396197%20AND%20SRC:MED&resulttype=core&format=json

Current Atherosclerosis Reports

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396197%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396197%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396197%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

190-192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396197%20AND%20SRC:MED&resulttype=core&format=json

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

25 January 2020

cites work

1 reference

12 December 2020

The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study p

1 reference

12 December 2020

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport

1 reference

12 December 2020

Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy

1 reference

12 December 2020

Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids

1 reference

12 December 2020

Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study

1 reference

12 December 2020

Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

1 reference

12 December 2020

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment

1 reference

12 December 2020

Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib

1 reference

12 December 2020

HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events

1 reference

12 December 2020

Major lipids, apolipoproteins, and risk of vascular disease

1 reference

12 December 2020

Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy

1 reference

12 December 2020

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

1 reference

12 December 2020